Overview

Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

Status:
Not yet recruiting

Trial end date:
2024-08-30

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to evaluate the colchicine protective effect in patients undergoing Percutaneous Coronary Intervention (PCI). The main question it aims to answer is: does initiating colchicine before planned PCI will reduce post-procedural myocardial injury? Half of the participants will receive colchicine, while the other half will receive a placebo.

Phase:

Phase 3

Details

Lead Sponsor:

Helwan University

Treatments:

Colchicine